20.48
3.98%
-0.85
アフターアワーズ:
20.48
Rapport Therapeutics Inc (RAPP) 最新ニュース
Perceptive Advisors LLC Invests $17.40 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Up 6.2% - MarketBeat
(RAPP) Technical Data - Stock Traders Daily
ARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
ARCH Venture Management LLC Invests $86.73 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals
Rapport Therapeutics Inc. (RAPP) rating initates by TD Cowen - Knox Daily
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 2.4% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 4.7% - Defense World
Reckitt shares up on report of potential homecare asset sale By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright - TipRanks
Quest Partners LLC Sells 5,882 Shares of iRobot Co. (NASDAQ:IRBT) - Defense World
Sofinnova Investments Inc. Invests $45.39 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 4.7% Higher - MarketBeat
RNAZ’s Financial Health: Exploring TransCode Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Trimble and Platform Science pushed hard to get deal done before Vegas meeting - Yahoo Finance
Johnson & Johnson Invests $58.11 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $19.00 - MarketBeat
(RAPP) Trading Advice - Stock Traders Daily
TD Asset Management Inc Takes Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
TD Asset Management Inc Invests $2.36 Million in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 5.5% - MarketBeat
The Potential Rise in the Price of Rapport Therapeutics Inc. (RAPP) following insiders activity - Knox Daily
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $21.20 - MarketBeat
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - GlobeNewswire
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - StockTitan
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - Yahoo Finance
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 5.8% - MarketBeat
Market Insights: Rapport Therapeutics Inc. (RAPP)’s Notable Gain of 9.85, Closing at 21.75 - The Dwinnex
Investing in Rapport Therapeutics Inc. (RAPP): What You Must Know - Knox Daily
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $20.40 - Defense World
Rapport Therapeutics to Present at 22nd Annual Morgan - GlobeNewswire
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit - StockTitan
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Yahoo Finance
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $20.40 - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.4% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 3.8% Higher - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 2.5% - MarketBeat
(RAPP) Investment Report - Stock Traders Daily
Stifel reiterates buy rating on Rapport Therapeutics shares, keeps $35 PT - Investing.com Canada
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.5% - MarketBeat
The 3 Best Healthcare Stocks to Buy in August 2024 - InvestorPlace
Rapport Therapeutics (NASDAQ:RAPP) Shares Up 10.2% - MarketBeat
Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Down to $18.56 - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Down to $18.56 - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Hits New 12-Month Low at $16.80 - MarketBeat
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - GlobeNewswire
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - WDRB
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - Yahoo Finance
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns - InvestorPlace
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 10.7% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 3% - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 3% - MarketBeat
He's helped 11 biotechs go public — without a science background - The Business Journals
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 8.9% - MarketBeat
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain - GlobeNewswire
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain - StockTitan
Beam CFO Burrell Returns to JPMorgan Investment Banking - BNN Bloomberg
NextGen Class of 2024 - BioSpace
Behind the Bell: Rapport Therapeutics - Nasdaq
Rapport Therapeutics Prices 8M Share IPO at $17/sh By Investing.com - Investing.com Nigeria
大文字化:
|
ボリューム (24 時間):